Overview of drugs approved by the FDA in 2022
The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were utilized. The search was conducted for the publicat...
Saved in:
Main Authors: | D. V. Kurkin (Author), E. I. Morkovin (Author), D. A. Bakulin (Author), Yu. V. Gorbunova (Author), Yu. A. Kolosov (Author), M. A. Dzhavakhyan (Author), I. E. Makarenko (Author), R. V. Drai (Author), A. V. Zaborovsky (Author), O. V. Shatalova (Author), A. V. Strygin (Author), V. I. Petrov (Author), A. P. Pleten (Author), A. A. Prokopov (Author), T. Yu. Tatarenko-Kozmina (Author) |
---|---|
Format: | Book |
Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024) -
Methodological and regulatory aspects of pharmaceutical development of biological products
by: D. V. Kurkin, et al.
Published: (2024) -
Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
by: D. V. Kurkin, et al.
Published: (2023) -
HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS
by: D. V. Kurkin, et al.
Published: (2023) -
Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development
by: V. I. Zvereva, et al.
Published: (2024)